Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Can Cannabis for Sleep Apnoea Cause Daytime Sedation or Motor Vehicle Accidents? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Managing obstructive sleep apnoea (OSA)  with cannabis requires careful consideration of safety. Evaluating cannabis and daytime sedation is essential to prevent impairment and reduce risks while promoting sleep benefits. 

Am I eligible for medical cannabis for pain relief?

Daytime Sedation and Safety Concerns 

Patients using cannabis for sleep apnoea may experience varying levels of drowsiness, making cannabis and daytime sedation an important factor in daily functioning and safety. Understanding this relationship helps mitigate potential hazards. 

Sedative Effects 

With Cannabis, daytime sedation can occur depending on cannabinoid type, dose, and timing. Excessive sedation may impact alertness and overall cognitive performance. 

Driving Risk 

The driving risk with cannabis increases when sedation is present. Motor vehicle operation under the influence of cannabinoids can significantly raise the chance of accidents. 

THC-Related Impairment 

Accident risk with THC highlights that high-THC cannabis may exacerbate daytime drowsiness. Patients should be informed about safe use and the need to avoid driving during peak sedative effects. 

Monitoring cannabis and daytime sedation is crucial for OSA patients. Awareness of driving risk with cannabis and accident risk with THC ensures safer integration of cannabis therapy into sleep apnoea management, supporting both therapeutic benefits and patient safety. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories